Committee on Safety of Medicines
|This article needs additional citations for verification. (December 2009) (Learn how and when to remove this template message)|
Following the thalidomide tragedy of 1957 to 1961, in 1963 the government asked Sir Derrick Dunlop to set up a committee to investigate the control and introduction of new medicines in the United Kingdom. In June 1963 the Committee on Safety of Drugs (CSD) was established. As a result of the subsequent report to the Department of Health, which reinforced the need for specially trained doctors in the pharmaceutical industry and academic departments of medicine, Dunlop became the first chairman of the Committee. In 1970, the CSD was replaced by the Committee on Safety of Medicines (CSM). The CSM was one of the advisory committees established by the Medicines Act 1968.[dead link]
- 1987-1993. Professor Sir William Asscher, previously chair of the Committee on the Review of Medicines
- "History and Aims of the Faculty of Pharmaceutical Medicine". Royal College of Physicians. Retrieved 2010-05-20.
- Daphne Christie; Tilli Tansey; Lois Reynolds, eds. (1998), Wellcome Witnesses to Contemporary Medicine, History of Modern Biomedicine Research Group http://www.histmodbiomed.org/witsem/vol2 Missing or empty
|title=(help), Wikidata Q29581621